- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 41/17 - Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
Patent holdings for IPC class A61K 41/17
Total number of patents in this class: 81
10-year publication summary
1
|
3
|
2
|
5
|
7
|
14
|
10
|
13
|
18
|
7
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Cerus Corporation | 91 |
4 |
Maco Pharma | 131 |
3 |
Ascendis Pharma A/S | 173 |
3 |
LG Chem, Ltd. | 17205 |
2 |
The General Hospital Corporation | 4517 |
2 |
Duke University | 2872 |
2 |
Able Corporation | 40 |
2 |
Advanced Aesthetic Technologies Inc. | 38 |
2 |
Bloodworks | 50 |
2 |
Case Western Reserve University | 1727 |
2 |
Colorado State University Research Foundation | 675 |
2 |
Elektrofi, Inc. | 25 |
2 |
Evelo Biosciences, Inc. | 135 |
2 |
Immunolight, LLC | 199 |
2 |
Korea Atomic Energy Research Institute | 418 |
2 |
National University Corporation Kobe University | 460 |
2 |
Rosalind Franklin University of Medicine and Science | 88 |
2 |
Synartro AB | 6 |
2 |
Hemanext Inc. | 80 |
2 |
Botanic Tonics, LLC | 15 |
2 |
Other owners | 37 |